CVRx, Inc. (CVRX): R&D Expense

Annual figures by period end, from SEC filings.

$11.13M
Year ended 2025-12-31
$12.36M
Trailing 12 months to 2026-06-30
+3.8%
3-year compound annual growth
+11.7%
5-year compound annual growth
$11.63M2020-12-31: $6.41M2021-12-31: $7.50M2022-12-31: $9.95M2023-12-31: $11.63M2024-12-31: $11.13M2025-12-31: $11.13M$11.13M
2020-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$11.13M0.0%2026-02-13, From 2025-01-01
2024-12-31$11.13M-4.3%2026-02-13, From 2024-01-01
2023-12-31$11.63M+16.9%2025-02-18, From 2023-01-01
2022-12-31$9.95M+32.7%2024-02-09, From 2022-01-01
2021-12-31$7.50M+17.0%2023-02-10, From 2021-01-01
2020-12-31$6.41Mn/a2022-02-22, From 2020-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
CVRx, Inc. (CVRX)2025-12-31$11.13M0.0%
LENSAR, Inc. (LNSR)2025-12-31$5.62M+5.5%
Apyx Medical Corp (APYX)2025-12-31$3.37M-33.6%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$2.38M-31.0%
Carlsmed, Inc. (CARL)2025-12-31$17.02M+19.0%
Shoulder Innovations, Inc. (SI)2025-12-31$7.73M+72.2%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$14.96M-15.4%
AVITA Medical, Inc. (RCEL)2025-12-31$20.84M+2.4%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.35M+101.0%

Compare CVRX, LNSR, APYX, MHUAF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗